SOCS1 and SOCS3 in the control of CNS immunity

Brandi J. Baker*, Lisa Nowoslawski Akhtar, Etty N. Benveniste

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

195 Scopus citations


In the decade following their initial discovery, the suppressor of cytokine signaling (SOCS) proteins have been studied for their potential use as immunomodulators in disease. SOCS proteins, especially SOCS1 and SOCS3, are expressed by immune cells and cells of the central nervous system (CNS) and have the potential to impact immune processes within the CNS, including inflammatory cytokine and chemokine production, activation of microglia, macrophages and astrocytes, immune cell infiltration and autoimmunity. We describe CNS-relevant in vitro and in vivo studies that have examined the function of SOCS1 or SOCS3 under various neuroinflammatory or neuropathological conditions, including exposure of CNS cells to inflammatory cytokines or bacterial infection, demyelinating insults, stroke, spinal cord injury, multiple sclerosis and glioblastoma multiforme.

Original languageEnglish (US)
Pages (from-to)392-400
Number of pages9
JournalTrends in Immunology
Issue number8
StatePublished - Aug 2009
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'SOCS1 and SOCS3 in the control of CNS immunity'. Together they form a unique fingerprint.

Cite this